Skip to main content
Caplight Logo









Labfront

Labfront

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.labfront.com/

Last Round

Accelerator

Aug 9, 2022

Est. Valuation

$1.67M

Total Funding Raised

$700,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Labfront is a healthcare technology company that provides a code-free digital biomarker collection and analytics platform for academic researchers.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Health IoT, Data Integration, Data Visualization

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

wearable dataremote patient monitoringRPMclinical researchhealth data analyticsdigital healthphysiological datadata integrationlongitudinal studywearable techdata pipelineheart rate variabilityHRVactigraphyhealth techresearch platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Labfront Comparables

Compare Labfront with similar companies based on industry and business-model similarity.

Labfront comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fitabase
91%
PhysioQ
87%
VivoSense
78%

Labfront Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 9, 2022
AcceleratorJul 12, 2022
Pre SeedJun 28, 2022

Key People

Founding team and executive leadership

Jordan Masys

Co-Founder & COO

Founding Team

Chris Peng

Chief Visionary Officer CEO

Executive Team

Labfront Investors

Notable investors and investment history

Labfront investors
InvestorRounds
500 GlobalPre Seed, Accelerator
Taiwan Tech ArenaAccelerator
MassChallenge IsraelAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 80% MoM.

  • Mar 9, 2026

    Collaborating with Zana Technologies GmbH on digital health research.

Labfront Filings

Explore SEC and related filing metadata, where available.

Labfront filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Labfront's valuation, stock price, and market status.

Is Labfront a public or private company?

Labfront is a private company.

What is the current stock price of Labfront?

Labfront is a private company with no public stock price. No recent secondary market data is available.

How much is Labfront worth (valuation)?

Valuation information for Labfront is not publicly available.

Can I buy Labfront stock?

Labfront shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Labfront's last funding round?

Labfront's most recent funding round was Accelerator on August 9, 2022.

Who are the main investors in Labfront?

Key investors in Labfront include 500 Global, Taiwan Tech Arena, MassChallenge.

Will Labfront IPO soon?

No public IPO plans have been announced for Labfront.

How can I track Labfront secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Labfront's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range15
Year Founded2021
Last FundingAug 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?